Speciality: Infectious diseases
Description:
A warm welcome to all the medical professionals in this interesting session on The Emergence of Omicron: A Variant of Concern - By Dr. Ashwini.
Dr. Ashwini discusses the emergence of Omicron, a variant of concern of the SARS-CoV-2 virus, which was first identified in South Africa in late 2021. Omicron quickly gained global attention due to its unprecedented number of mutations in the spike protein, raising concerns about increased transmissibility and potential resistance to existing vaccines and treatments.
Omicron's rapid spread has been attributed to its ability to evade immunity from previous infections and vaccinations more effectively than earlier variants. Dr. Ashwini highlights that, despite its higher transmissibility, preliminary data suggested that Omicron might cause less severe disease compared to the Delta variant. However, the sheer volume of cases posed significant challenges to healthcare systems worldwide, leading to increased hospitalizations and strain on medical resources.
To combat Omicron, Dr. Ashwini emphasizes the importance of booster vaccination campaigns, which have shown to enhance protection against this variant. Additionally, ongoing research and adaptation of COVID-19 treatments and preventive measures are crucial in addressing the evolving threat posed by Omicron and future variants. Public health strategies, including widespread testing, genomic surveillance, and reinforcing public health measures, remain essential in mitigating the impact of Omicron.
Therefore, get an overall knowledge of Th
See More Webinars @ Hidoc Webinars
1.
Targeted radiation therapy shows near-complete response in rare sarcoma patients
2.
Dostarlimab Boosts Long-Term Survival in Endometrial Cancer
3.
Germline Profiling May Improve Risk Stratification in t-MNs
4.
Results for Prostate Cancer Are Associated With PSA Nadir 6 Months After Primary RT.
5.
Scientists call into question safety of potential new anticancer treatment
1.
Understanding Macrocytosis: Causes, Symptoms, and Treatment Options
2.
Gender-Specific Dual Antiplatelet Therapy Strategies for Women After PCI
3.
Unlocking the Mystery of Hemoglobin C Trait: A Closer Look at a Rare Blood Disorder
4.
Ferroptosis Signaling in Tumor Progression and Therapeutic Resistance
5.
Exploring New Treatment Options for Hemophilia: A Journey into the Unknown
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
2.
Navigating the Complexities of Ph Negative ALL - Part XV
3.
Clinical Insights in Hematology
4.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
5.
Updates on the First Line Management of ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation